Berad · Checked.be

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Berad is < 0.1% (very low). The 2025 annual accounts show equity of €1.74M and a net result of €374k. Equity is growing by ~3.7% per year across the filed fiscal years. Its solvency ranks better than 90% of 2210 sector peers (fiscal year 2025). The company has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 7 annual accounts.

Signals

3 signals · with evidence

Strong solvency vs sector

Solvency is in the sector's strongest quartile: better than 90% of 2210 peers (2025). A comfortable equity buffer.

View the sector comparison

Consistently profitable

Positive net result in the two most recent financial years (2024 and 2025).

View the result trend

Growing equity

Equity grew over 2023-2025. Profits are largely retained rather than distributed.

View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide

Latest accounts filed on time

The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 16-01-2026, 15 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.

The next deadline is still running

The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.

How we compute the deadline

The year end is derived from 10 filed financial years, each closing on 30-06. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 30-06-2025, that is 31-01-2026.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
30-06-2025	31-01-2026	16-01-2026	15 d early	2026-00008763
30-06-2024	31-01-2025	30-01-2025	1 d early	2025-00020632
30-06-2023	31-01-2024	29-01-2024	2 d early	2024-00024122
30-06-2022	31-01-2023	30-01-2023	1 d early	2023-00015233
30-06-2021	31-01-2022	26-01-2022	5 d early	2022-02100584
30-06-2020	31-01-2021	21-01-2021	10 d early	2021-01300344
30-06-2019	31-01-2020	18-12-2019	44 d early	2019-76500051
30-06-2018	31-01-2019	13-12-2018	49 d early	2018-74300343
30-06-2017	31-01-2018	22-12-2017	40 d early	2017-72800476
30-06-2016	31-01-2017	16-12-2016	46 d early	2016-70300101

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

Established

Founded in 2006, 19 years in business.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

< 0.1% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Annual accounts: healthy financial profile −Long track record −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€374k+56.3%

Working capital€1.74M+19.0%

CSV export

Annual accounts & ratios

Source: NBB · 2025

Annual accounts filed on 16-01-2026 with the NBB · fiscal year 2025 · micro

Operating resultNet result

Trajectory (indicative)

Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.

growing Equity: growth of ~3.7%/year over 7 fiscal years, indicative, assuming unchanged policy.

Solid line = filed figures · dashed = extended trend · area = indicative range.

How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison

Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	92.6%	58.1%	better than 90% of 2210 sector peers
Net result	€374k	€60k	better than 95% of 2208 sector peers
Equity	€1.74M	€74k	better than 95% of 2210 sector peers
Gross operating margin	€534k	€96k	better than 95% of 2210 sector peers
Total assets	€1.88M	€186k	better than 95% of 2210 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

Sector position over time

Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).

Solvency P90

Stable position over 2020-2025 · n=635-6575

Net result P95

Stable position over 2020-2025 · n=636-6569

Equity P95

Stable position over 2020-2025 · n=635-6575

Gross operating margin P95

Stable position over 2020-2025 · n=635-6577

Describes the position versus peers, not a forecast.

EBITDA

€529k

+53.3% 19-25

Net profit

€374k

+56.3% 19-25

Cash flow

€375k

+56.1% 19-25

Total assets

€1.88M

+22.5% 19-25

Equity

€1.74M

+19.2% 19-25

Working capital

€1.74M

+19.0% 19-25

Income taxes

€173k

+59.3% 19-25

Dividends

€94k

-0.2% 19-25

Debt

€138k

+88.3% 19-25

Debt ≤ 1y

€138k

+88.3% 19-25

Current ratio

13.56

-35.0% 19-25

Quick ratio

13.56

-35.0% 19-25

Solvency

92.6%

-2.7% 19-25

Debt / equity

0.08

+58.0% 19-25

ROE

21.5%

+31.1% 19-25

ROA

19.9%

+27.6% 19-25

Interest coverage

493.07

+430.6% 19-25

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2025
Deposit	micro
Revenue	-
EBITDA	€529k
Net profit	€374k
Cash flow	€375k
Staff costs	-
Income taxes	€173k
Dividends	€94k
Total assets	€1.88M
Equity	€1.74M
Debt	€138k
of which ≤ 1y	€138k
of which > 1y	-
Working capital	€1.74M
Employees (FTE)	-

Ratios (computed)

	2025
Current ratio	13.56
Quick ratio	13.56
Working capital ratio	92.5%
Solvency	92.6%
Debt / equity	0.08
Long-term debt ratio	-
Interest coverage	493.07
Gross margin	-
Net margin	-
ROA	19.9%
ROE	21.5%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2025

Assets

Fixed assets €4k · 0.2% Current assets €1.87M · 99.8%

Equity & liabilities

Equity €1.74M · 92.6% Debt €138k · 7.4%

Full annual accounts

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€1.88M
Fixed assets	21/28	€4k
Tangible fixed assets	22/27	€4k
Current assets	29/58	€1.87M
Amounts receivable within one year	40/41	€0
Investments	50/53	€1.43M
Cash & bank	54/58	€438k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€1.88M
Equity	10/15	€1.74M
Contributions / capital	10/11	€12k
Reserves	13	€1.73M
Accumulated profits (losses)	14	€0
Amounts payable	17/49	€138k
Amounts payable within one year	42/48	€138k
Trade debts payable within one year	44	€3k
Income statement
Gross operating margin	9900	€534k
Operating result	9901	€528k
Financial income	75	€20k
Financial charges	65	€1k
Result before taxes	9903	€547k
Income taxes	67/77	€173k
Net result for the period	9904	€374k
Result to be appropriated	9905	€374k

You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan. See plans →

Ratios computed by Checked.

Health barometer

FY 2025 · computed

100 / 100 Excellent

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Boeimeerstraat 352820 Bonheiden

Establishment units

1 location

BERAD

Boeimeerstraat 35, 2820 BonheidenMedische praktijken

since 20062.261.961.311

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels1

Ground area2,710 m²

Buildings1

Building footprint235 m²

Volume (LiDAR)1,288 m³

Tallest building6.7 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
12005C0141/00D003	Flanders	2,710 m²	1 · 235 m²	6.7 m · 2 fl.

Methodology

via registered seat: 1

1 of 1 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

No structured acts for this company yet

That means one of two things: the company has published no company deeds, or its deeds are still queued for reading. The insolvency signals above come from a separate source; the KBO register is the second source and appears as the legal situation on this page.

Analysis

Snowflake analysis

financial profile on 5 axes

96 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 100

Profitability 100

Solvency 100

Growth 78

Stability 100

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers

Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon

The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works